AstraZeneca Group plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (45)

Latest Posts

About This Stock More About This Stock
Merck KGaA And Pfizer Get FDA Approval Of Checkpoint Inhibitor "Avelumab" For Rare Merkel Cell Skin Cancer Therapy
Article By: Lorimer Wilson
Friday, March 24, 2017 10:17 AM EDT
Biopharma partners Merck KGaA and Pfizer came away with their first FDA approval of the checkpoint inhibitor avelumab, making it the fourth drug in this category to make it to the market.
In this article: MRK, PFE Also: AZN, BMY
Read
Quiet Start To Quad-Witching St. Paddy's Day: Futures Flat, Global Stocks Mixed
Article By: Tyler Durden
Friday, March 17, 2017 7:11 AM EDT
European stocks mixed, Asian shares and U.S. index futures (-0.1%) little changed ahead of industrial production data with just Tiffany's set to report earnings.
In this article: GLD, OIL, SPY, UDN, AZN, MS, AMZN, FXE, AAPL
Read
E Biotech Pulse! Sector Has Momentum
Article By: Tarun Chandra, CFA
Tuesday, March 14, 2017 11:00 PM EDT
Biotech sector is poised for further gains this year after a strong start. The nomination of an industry-favored FDA head is a positive. There is a possibility of receiving some clarity soon on Medicare price negotiation issue as well.
In this article: IBB Also: AZN, VRX, ARRY, QQQ, CLVS, EXEL, GILD, SPY, TSRO
Read
E Best And Worst ADRs - Monday, March 13
Article By: E.B. Capital Markets
Monday, March 13, 2017 2:01 PM EDT
The average ADR in our universe rallied 0.77% last week and is trading -14.86% below its 52 week high, 4.05% above its 200 dma, and has 3 days to cover held short.
In this article: ASR, ASX, AZN, BMO, BP, CEA, CNQ, CS, CUK, LUX, NOAH, RY, TEO, TV, UMC, WBK, DASTY, MXCYY, NABZY, CTRP, OIIM, GGAL, AVDL
Read
How Incyte Stock Became A Bull Market Star For Biotech Investors
Article By: Arpita Dutt
Friday, March 10, 2017 9:17 AM EDT
Despite many twists and turns, the U.S. stock market has had a stupendous run since it reached a bottom in Mar 2009. The bull run has continued for eight years with the S&P 500 gaining 198.1% during this period.
In this article: INCY Also: GILD, NVS, LLY, MRK, RHHBY, AZN
Read

PARTNER HEADLINES

Latest Tweets for $AZN

No tweets yet!